Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults
Clinical trial NCT05868382 · COMPLETED
Trial details
- NCT number
- NCT05868382
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-15
- Primary completion
- 2023-12-19
- Enrollment
- 270
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.